Live Breaking News & Updates on Early Prostate Cancer

Stay updated with breaking news from Early prostate cancer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Prostate-specific antigen failure risk factors in nonmetastatic unfavorable-risk prostate cancer

Prostate-specific antigen failure risk factors in nonmetastatic unfavorable-risk prostate cancer
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Dana Farber Cancer Institute , United States , Martinw Schoen , Mutlay Sayan , Sciencex Network , Cumulative Incidence Curves , Short Term Prostate Specific Antigen Recurrence , Patients With Prostate Cancer , Recurrence After Radiation , Early Prostate Cancer , Risk Stratification From Prospective Trials ,

Advaxis to Present Updated Clinical and Immunogenicity Data

Overall response rate of 14% and disease control rate of 36% in Part B of ADXS-503 trial with durable clinical benefit as an add-on therapy to patients. ....

United States , New Jersey , American Society Of Clinical Oncology , Advaxis Inc , Present Updated Clinical , Immunogenicity Data , Ongoing Phase , Metastatic Non Small Cell Lung Cancer , Study Design , Early Prostate Cancer , American Society , Clinical Oncology , Other Otc Adxs ,